Mechanical circulatory support devices market seen reaching $5.59 billion by 2030

The mechanical circulatory support devices market is projected to grow from $3.47 billion in 2025 to $3.82 billion in 2026, driven by rising heart failure cases and broader use of advanced cardiac support technology. The Business Research Company says the market could reach $5.59 billion by 2030, with North America leading now and Asia-Pacific expected to grow fastest.

Why it matters: - Mechanical circulatory support devices are used to help or replace the heart’s pumping function in patients with severe heart failure and other cardiovascular conditions. - The market growth reflects rising demand for cardiac care tools that can stabilize patients, support blood flow and, in some cases, bridge patients to transplant or recovery. - The expansion also signals growing use of advanced cardiac procedures, minimally invasive approaches and specialty heart-care infrastructure.

What happened: - The Business Research Company released a 2026 market report on mechanical circulatory support devices. - The report estimates the market will rise from $3.47 billion in 2025 to $3.82 billion in 2026, a 10.1% compound annual growth rate. - The report forecasts the market will reach $5.59 billion by 2030, implying a 10.0% CAGR over the period. - North America held the largest market share in 2025. - Asia-Pacific is forecast to be the fastest-growing region in the coming years.

The details: - The report links near-term growth to limited availability of advanced support devices, continued reliance on intra-aortic balloon pumps, more heart failure cases, more cardiac surgeries and a lack of standardized implantation training. - Longer-term growth is supported by improvements in pulsatile and non-pulsatile flow devices, wider use of minimally invasive cardiac procedures and greater adoption of left and biventricular assist devices. - The report also points to growth in hospitals and specialty cardiac centers as a demand driver. - Increased investment in cardiac care research and development is another factor behind the market outlook. - Key trends include rising use of ventricular assist devices and total artificial hearts, broader ECMO use, more percutaneous deployment and tighter compliance with regulatory and safety standards. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report’s enhanced 2026 edition includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and key technology and future trend analysis. - More information is available in the full report and a free sample.

Between the lines: - Rising heart failure prevalence is the clearest demand signal in the report. - In September 2024, the Heart Failure Society of America said 6.7 million Americans over age 20 were living with heart failure. - The Heart Failure Society of America projects that number could reach 8.7 million by 2030, 10.3 million by 2040 and 11.4 million by 2050. - That trajectory suggests mechanical circulatory support devices may gain importance as patient volumes rise and treatment complexity increases.

What's next: - The market is expected to keep expanding as hospitals, specialty centers and cardiac device makers push into more advanced support systems. - Adoption of minimally invasive and percutaneous device deployment is likely to remain a key area to watch. - Regional growth could shift more quickly toward Asia-Pacific as healthcare capacity and cardiac care demand expand there.

The bottom line: - The mechanical circulatory support devices market is moving from niche support toward a larger, faster-growing segment of cardiac care.